Huadong Medicine Co., Ltd (SHE:000963)

Market Cap	63.19B +8.5%
Revenue (ttm)	43.09B +3.3%
Net Income	3.70B +15.1%
EPS	2.11 +14.8%
Shares Out	1.75B
PE Ratio	17.15
Forward PE	17.33
Dividend	0.93 (2.58%)
Ex-Dividend Date	n/a

Volume	8,811,236
Average Volume	8,903,336
Open	34.84
Previous Close	36.05
Day's Range	34.84 - 36.37
52-Week Range	33.30 - 47.36
Beta	0.37
RSI	52.82
Earnings Date	Apr 24, 2026

About Huadong Medicine

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 18,265
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2024, Huadong Medicine's revenue was 41.91 billion, an increase of 3.16% compared to the previous year's 40.62 billion. Earnings were 3.51 billion, an increase of 23.72%.